Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-1997 | 04-1997 | 01-1997 | 10-1996 | 07-1996 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 1,980 | 2,650 | 3,150 | 3,980 | 20 |
| Receivables | 240 | 380 | 300 | 220 | 180 |
| Inventories | 20 | 20 | 10 | 10 | 50 |
| Other current assets | 590 | 290 | 360 | 20 | 20 |
| TOTAL | $2,830 | $3,340 | $3,820 | $4,230 | $270 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 30 | 10 | 5 | 0 |
| Other Non-Current Assets | 60 | 10 | 10 | 0 | 7 |
| TOTAL | $60 | $40 | $20 | $5 | $7 |
| Total Assets | $3,630 | $3,960 | $4,390 | $4,690 | $810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 90 | 190 | 170 | 40 | 230 |
| Accrued Expenses | 60 | 200 | 200 | 340 | 300 |
| TOTAL | $150 | $400 | $370 | $380 | $940 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 1 | 2 | 3 |
| TOTAL | $N/A | $N/A | $1 | $2 | $3 |
| Total Liabilities | $150 | $400 | $371 | $382 | $943 |
| Shareholders' Equity | |||||
| Common Shares | 5,560 | 5,260 | 5,260 | 5,180 | 660 |
| Retained earnings | -2,190 | -1,700 | -1,250 | -880 | -790 |
| Other shareholders' equity | 100 | 0 | 0 | 0 | 10 |
| TOTAL | $3,470 | $3,560 | $4,010 | $4,300 | $-120 |
| Total Liabilities And Equity | $3,620 | $3,960 | $4,381 | $4,682 | $823 |